NLCP And MSOS: Cannabis REIT Vs. ETF
NLCP’s 12% dividend yield, low debt, and resilient rent collections add downside defense amid cannabis oversupply risks. See more here.
Why The Story Around Trulieve Cannabis (CNSX:TRUL) Is Shifting With New Valuation Assumptions
Trulieve Cannabis is back in focus after an updated fair value estimate edges from CA$19.53 to CA$20.36, a measured reset rather than a sweeping overhaul. That shift lines up with broader Street …
Assessing Trulieve Cannabis (CNSX:TRUL) Valuation After New Dabstract Partnership And Recent Share Price Moves
Why the Dabstract partnership matters for Trulieve Cannabis The latest move driving attention to Trulieve Cannabis (CNSX:TRUL) is its new partnership with concentrate brand Dabstract to bring High …
NewLake Capital Partners: Collect A Double-Digit Yield From This Cannabis Landlord
NewLake Capital Partners (NLCP) offers a near-12% yield with strong occupancy, low debt and rising dividends—an overlooked cannabis REIT.
Canadians could claim part of $8-million cannabis settlement
Canadians who invested in cannabis stock could cash in on a hefty class-action settlement against Wayland Group Corp.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Tilray Brands (TLRY) Price Forecast: Cannabis Rescheduling Fuels Recovery
Trend Identification & Analysis: How to Read the Market’s Footprints Before the Crowd Does Cannabis-related stocks and ETFs have been among the worst-performing groups in recent years. A peak was …
MSOS: Trump’s Green Light – Why Cannabis Stocks Are Surging On Rescheduling News (Rating Upgrade)
MSOS is upgraded to Buy ahead of US cannabis rescheduling catalysts—Schedule III could end 280E taxes, boost MSO profits, and drive re-ratings. Read more here.
Why are cannabis stocks surging today?
Shares of major cannabis companies rallied sharply on Wednesday after reports suggested the Trump Administration could soon move to reclassify marijuana, a long-awaited step that investors believe …
Canadian Cannabis Stocks Jump on Report U.S. May Move to Reclassify Marijuana
Canadian cannabis companies surged Wednesday after an Axios report said that the Trump Administration could move to reclassify marijuana.
Thinking about buying Canopy Growth stock? You may want to wait for this to happen first
The main reason for investing in Canopy Growth over the years has been due to the hope that the U.S. might legalize marijuana.
Cannabis operator CRON rises 46% in a year: Time to buy, sell or hold?
Shares of Cronos Group CRON have staged a strong recovery over the past year. The Canada-based cannabis operator’s shares have risen 46% in the said time frame, significantly outperforming the …
This cannabis stock will beat the market, analyst says
Haywood Capital Markets analyst Neal Gilmer has reiterated his “Buy” rating and $1.30 target price on Rubicon Organics …
Debt dominates cannabis capital raises as equity deals dry up
The cannabis industry has transitioned to a more commoditized market characterized by price declines and minimal organic growth.
1 stock I’d buy today, 1 I wouldn’t touch
Investing is about picking the right stocks and avoiding the wrong ones. While some companies are capitalizing on powerful trends, others continue to struggle despite industry tailwinds. Before I dive …
Recent Comments